Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; post r1 or r2 resection (with or without neoadjuvant therapy) with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)
This is the 2006 version of HCPCS G9101 - please refer to the 2016 HCPCS code set for the latest version.
Status changed on Sunday, January 01, 2006 to: Add procedure or modifier code